AI-Driven Discovery of Safe, Tumor-Specific Immunotherapies Through the Lenses of RNA Splicing

Time: 1:00 pm
day: Day Two


  • Using AI to analyze RNA-seq data and prioritize neoepitopes encoded by tumor-specific splicing isoforms
  • Delve into the use of biopsies from different cohorts of patients with tumor vs. normal tissues to avoid off-target effects
  • Validated novel neoepitopes predicted with AI through a case study in triple negative breast cancer